Skip to content
10-Q

Quarterly Report

CG Oncology, Inc. CGON

0000950170-25-105855

← back to feed
Filed
Aug 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 6, 2025 76.25M sh
Shares Diluted Q2 2025 · Jun 30, 2025 76.23M sh
Shares Diluted Q2 2025 · Jun 30, 2025 76.21M sh
Shares Diluted Q2 2025 · Jun 30, 2024 66.65M sh
Shares Diluted Q2 2025 · Jun 30, 2024 56.86M sh
Capex Q2 2025 · Jun 30, 2025 $30K
Capex Q2 2025 · Jun 30, 2024 $26K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$57.24M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$42.13M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $14.62M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $257.07M
Stockholders Equity Q2 2025 · Jun 30, 2025 $670.36M
Stockholders Equity Q2 2025 · Mar 31, 2025 $704.76M
Stockholders Equity Q2 2025 · Dec 31, 2024 $733.38M
Stockholders Equity Q2 2025 · Jun 30, 2024 $552.36M
Stockholders Equity Q2 2025 · Mar 31, 2024 $568.94M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$123.1M
Current Liabilities Q2 2025 · Jun 30, 2025 $30.38M
Current Liabilities Q2 2025 · Dec 31, 2024 $21.37M
Total Liabilities Q2 2025 · Jun 30, 2025 $31.09M
Total Liabilities Q2 2025 · Dec 31, 2024 $21.42M
Current Assets Q2 2025 · Jun 30, 2025 $673.03M
Current Assets Q2 2025 · Dec 31, 2024 $754.21M
Total Assets Q2 2025 · Jun 30, 2025 $701.45M
Total Assets Q2 2025 · Dec 31, 2024 $754.8M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.54
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.00
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.28
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.63
Eps Basic Q2 2025 · Jun 30, 2025 −$0.54
Eps Basic Q2 2025 · Jun 30, 2025 −$1.00
Eps Basic Q2 2025 · Jun 30, 2024 −$0.28
Eps Basic Q2 2025 · Jun 30, 2024 −$0.63
Sga Expense Q2 2025 · Jun 30, 2025 $17.41M
Sga Expense Q2 2025 · Jun 30, 2025 $32.2M
Sga Expense Q2 2025 · Jun 30, 2024 $7.49M
Sga Expense Q2 2025 · Jun 30, 2024 $13.28M
Rd Expense Q2 2025 · Jun 30, 2025 $31.33M
Rd Expense Q2 2025 · Jun 30, 2025 $58.8M
Rd Expense Q2 2025 · Jun 30, 2024 $18.47M
Rd Expense Q2 2025 · Jun 30, 2024 $35.68M
Net Income Q2 2025 · Jun 30, 2025 −$41.43M
Net Income Q2 2025 · Jun 30, 2025 −$75.88M
Net Income Q2 2025 · Mar 31, 2025 −$34.45M
Net Income Q2 2025 · Jun 30, 2024 −$18.9M
Net Income Q2 2025 · Jun 30, 2024 −$35.84M
Net Income Q2 2025 · Mar 31, 2024 −$16.93M
Operating Income Q2 2025 · Jun 30, 2025 −$48.74M
Operating Income Q2 2025 · Jun 30, 2025 −$90.95M
Operating Income Q2 2025 · Jun 30, 2024 −$25.85M
Operating Income Q2 2025 · Jun 30, 2024 −$48.32M
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2025 $52K
Revenue Q2 2025 · Jun 30, 2024 $111K
Revenue Q2 2025 · Jun 30, 2024 $640K